Cullen Investment Group’s AbbVie ABBV Stock Holding History

Cullen Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.24M	Buy	12,865 +2	+0%	+$430	0.39%	56
2026 Q1	$2.8M	Buy	12,863 +10	+0.1%	+$2.22K	0.37%	63
2025 Q4	$2.83M	Sell	12,853 -313	-2%	-$71.3K	0.37%	67
2025 Q3	$3.08M	Sell	13,166 -322	-2%	-$65.6K	0.41%	56
2025 Q2	$2.5M	Sell	13,488 -139	-1%	-$25.8K	0.35%	60
2025 Q1	$2.86M	Sell	13,627 -98	-0.7%	-$19.1K	0.43%	60
2024 Q4	$2.44M	Buy	13,725 +210	+2%	+$38.6K	0.36%	59
2024 Q3	$2.67M	Buy	13,515 +219	+2%	+$40.9K	0.4%	61
2024 Q2	$2.28M	Sell	13,296 -302	-2%	-$50K	0.36%	62
2024 Q1	$2.46M	Buy	13,598 +317	+2%	+$54.6K	0.39%	59
2023 Q4	$2.06M	Buy	+13,281	New	+$1.94M	0.36%	61

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Cullen Investment Group's ABBV Position: Q2 2026 in Review

Cullen Investment Group increased its AbbVie (ABBV) stake by 0.02% in Q2 2026, buying an estimated $430 and bringing the position to 12,865 shares worth $3.24M. The position accounts for 0.39% of the portfolio, ranked #56.

Cullen Investment Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,042 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cullen Investment Group held 12,865 shares of AbbVie worth $3.24M as of Q2 2026.
Cullen Investment Group bought 2 AbbVie shares in Q2 2026, an estimated $430.
AbbVie made up 0.39% of Cullen Investment Group's portfolio in Q2 2026, its #56 holding.
Cullen Investment Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
1,042 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cullen Investment Group's 13F filing for Q2 2026, filed 9 Jul 2026.